This paper demonstrates that GPS could effectively alleviate NAFLD by elevating cell viability, reducing fatty deposition, downregulating TG, and activating nucleus Nrf2 in FFA-induced HepG2 cells. Here, NFE2L2 is linked to metabolic dysfunction-associated steatotic liver disease.